Related Experiment Video
Updated: Jun 2, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Urinary markers for prostate cancer
1UNIV TEXAS,MD ANDERSON CANC CTR,DEPT GENITOURINARY MED ONCOL,HOUSTON,TX 77030.
Abstract:
Immunoglobulins (Igs), bombesin-like immunoreactivity (BLI), beta-2 microglobulin (beta-2m) and transferrin were measured by radioimmunoassay in the first voided urine of patients with advanced prostatic carcinoma. Compared to 16 age-matched, healthy subjects, urinary Igs were elevated in 19 (48%), BLI in 12 (30%), beta-2m in 29 (74%) and transferrin in 8 (20%) of 40 adenocarcinoma patients. Elevation in urinary Igs, BLI or beta-2m was associated with a significantly shorter survival. The four urine markers correlated well with serum chromogranin A but not with serum prostate-specific antigen. Results suggest that these urine markers are elevated with high frequency in advanced prostate cancer.
Related Concept Videos
Urine Studies I: Urinalysis
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Imaging Studies IV: Magnetic Resonance Imaging
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Serum Studies: Renal Function Tests
Nursing Assessment of the Genitourinary System I: Health History

